Beam Therapeutics CEO John M. Evans Reports Sale of $1.19 Million in Common Shares
Beam Therapeutics CEO and director John M. Evans sold 50,000 common shares on October 15-16, 2026. Sales totaled 25,000 shares at $23.566 on October 15, with another 25,000 shares sold at $23.9838 on October 16. Evans exercised stock options for 25,000 common shares on each date at $1.03 per share. Direct common stock